Hsieh et al. studied the in vivo DPP-IV inhibitory activity of Atlantic salmon skin gelatin hydrolysate using rats with streptozotocin (STZ)-induced diabetes [88]. This evidence concerns the gene DPP4 and diabetes mellitus.